BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 7506674)

  • 1. Inhibition of erythroid differentiation by stem cell factor in K562 cells expressing the c-kit gene.
    Ogawa K; Tashima M; Toi T; Sawai H; Sawada H; Fujita J; Maruyama Y; Okuma M
    Exp Hematol; 1994 Jan; 22(1):45-51. PubMed ID: 7506674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat.
    Fujio K; Evarts RP; Hu Z; Marsden ER; Thorgeirsson SS
    Lab Invest; 1994 Apr; 70(4):511-6. PubMed ID: 7513770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
    Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
    J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
    Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
    Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of stem cell factor on the growth and radiation survival of tumor cells.
    Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
    Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue.
    Strohmeyer T; Reese D; Press M; Ackermann R; Hartmann M; Slamon D
    J Urol; 1995 Feb; 153(2):511-5. PubMed ID: 7529338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor (GM-CSF) reduces the density of stem cell factor receptors (c-kit oncogene product) on a GM-CSF-dependent human myeloid cell line.
    Oez S; Hofmann-Wackersreuther G; Birkmann J; Smetak M; Welte K; Gallmeier WM
    Eur Cytokine Netw; 1993; 4(4):293-7. PubMed ID: 7505637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of the c-kit and stem cell factor genes in breast carcinomas.
    Hines SJ; Organ C; Kornstein MJ; Krystal GW
    Cell Growth Differ; 1995 Jun; 6(6):769-79. PubMed ID: 7545433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-kit protein (stem cell factor receptor) expression on cells with erythroid characteristics and on normal human bone marrow without the use of monoclonal antibodies.
    McGuckin CP; Uhr MR; Gordon-Smith EC
    Exp Hematol; 1995 Jan; 23(1):14-20. PubMed ID: 7527782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of stem cell factor (SCF) and c-kit mRNA in human placental tissue and biological effects of SCF on DNA synthesis in primary cultured cytotrophoblasts.
    Saito S; Enomoto M; Sakakura S; Ishii Y; Sudo T; Ichijo M
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1762-9. PubMed ID: 7529021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the erythropoietin and stem-cell-factor receptors.
    Wu H; Klingmüller U; Besmer P; Lodish HF
    Nature; 1995 Sep; 377(6546):242-6. PubMed ID: 7545788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors.
    Inoue M; Kyo S; Fujita M; Enomoto T; Kondoh G
    Cancer Res; 1994 Jun; 54(11):3049-53. PubMed ID: 7514496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
    Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
    Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine KIT+ lineage- bone marrow progenitors express Fc gamma-RII but do not express Fc epsilon-RI until mast cell granule formation.
    Lantz CS; Huff TF
    J Immunol; 1995 Jan; 154(1):355-62. PubMed ID: 7527815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEG-01s cells have receptors for and respond to IL-3, IL-6, and SCF.
    Kellar KL; Hooper WC; Benson JM
    Exp Hematol; 1995 Jun; 23(6):557-64. PubMed ID: 7539384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors.
    Gore SD; Amin S; Weng LJ; Civin CI
    Exp Hematol; 1995 May; 23(5):413-21. PubMed ID: 7536683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the density of the stem cell factor receptor (c-kit) by tumor necrosis factor alpha on a human myeloid cell line.
    Oez S; Birkmann J; Smetak M; Corbacioglu S; Hofmann-Wackersreuther G; Welte-K ; Gallmeier WM
    Eur Cytokine Netw; 1993; 4(6):439-45. PubMed ID: 7514454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-KIT expression enhances the leukemogenic potential of 32D cells.
    Hu Q; Trevisan M; Xu Y; Dong W; Berger SA; Lyman SD; Minden MD
    J Clin Invest; 1995 Jun; 95(6):2530-8. PubMed ID: 7539453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of c-kit receptor and its ligand in increase of mast cells in neurofibroma tissues.
    Hirota S; Nomura S; Asada H; Ito A; Morii E; Kitamura Y
    Arch Pathol Lab Med; 1993 Oct; 117(10):996-9. PubMed ID: 7692836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.